Cargando…
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
BACKGROUND: Ovarian cancer is associated with poor long-term survival due to late diagnosis and development of chemoresistance. Tumour hypoxia is associated with many features of tumour aggressiveness including increased cellular proliferation, inhibition of apoptosis, increased invasion and metasta...
Autores principales: | McEvoy, Lynda M., O’Toole, Sharon A., Spillane, Cathy D., Martin, Cara M., Gallagher, Michael F., Stordal, Britta, Blackshields, Gordon, Sheils, Orla, O’Leary, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513971/ https://www.ncbi.nlm.nih.gov/pubmed/26205780 http://dx.doi.org/10.1186/s12885-015-1539-8 |
Ejemplares similares
-
Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells
por: Egan, Karl, et al.
Publicado: (2011) -
An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines
por: Vencken, Sebastian F, et al.
Publicado: (2014) -
Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade
por: Cluxton, Christopher D., et al.
Publicado: (2019) -
The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer
por: Bates, Mark, et al.
Publicado: (2020) -
The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival
por: Rae, Sophie, et al.
Publicado: (2022)